Fundraising Fox1315 Capital — 2017 Investments
5 investments dated 2017 · listed companies and verified rows first · show all
Offers soft tissue repair solutions combining naturally sourced tissue with polymer; lead product OviTex for hernia repair (NASDAQ: TELA), based in Malvern, PA.
BiotechMalvern, US
Antony Koblish(Founder)inFrancis Conway(Executive Officer)Maarten Persenaire(Executive Officer)Christine Arasin(Executive Officer)
BoardKevin Rakin(Director)inAshley Freidman(Director)
Board seatAdele C. Oliva· per SEC Form D · $7.5M raise · filed Jan 2017
Co-investorsCheckmate Capital Group LLCEssex Woodlands Healthcare PartnersHighCape CapitalOrbiMedSignet Healthcare PartnersRTW Investments L.P.
Colorescience is a professional skincare brand that develops mineral-based sun protection (SPF), skincare, and color correction products, originally created for post-procedure skin and marketed for all ages and skin types.
ConsumerDirect to ConsumerHealthtechWellness & FitnessCarlsbad, US
Stephen Loomis(Executive Officer)Mary Fisher(Executive Officer, Director)inTheodore Ebel(Executive Officer)Josie Juncal-Schwarz(Executive Officer)
BoardM Bolyard(Director)Brian Dovey(Director)in
Board seatAdele C. Oliva· per SEC Form D
Co-investorsAisling CapitalRevelation PartnersDomain AssociatesHealthCare Ventures, LLCLongwood FundMontreux Equity Partners+2 more
Onkos Surgical develops limb salvage and orthopedic reconstruction implants and systems for treating musculoskeletal cancer and complex orthopedic conditions.
HardwareHealthtechMedical DevicesParsippany, US
Patrick Treacy(Founder)inAntony Koblish(Director, Promoter)inBrad Tyler(Executive Officer)in
BoardAdele Oliva(Director)inStephen Bloch(Director)inPaul Touhey(Director)
Board seatAdele C. Oliva· per SEC Form D
Co-investorsCanaan PartnersJSD Capital, LLCSV Health Investors
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.